LOGIN
ProDisc-C total disc arthroplasty vs ACDF in single-level cervical disc disease at 7 years
February 2016
ProDisc-C total disc arthroplasty vs ACDF in single-level cervical disc disease at 7 years
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:1
ProDisc-C Total Disc Replacement Versus Anterior Cervical Discectomy and Fusion for Single-Level Symptomatic Cervical Disc Disease: Seven-Year Follow-up of the Prospective Randomized U.S. Food and Drug Administration Investigational Device Exemption Study
J Bone Joint Surg Am. 2015 Nov 4;97(21):1738-47Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
209 patients with single-level cervical degenerative disc disease were randomized to undergo either anterior cervical discectomy and fusion (ACDF) or total disc arthroplasty (with ProDisc-C). The purpose of this randomized controlled trial was to report the 7-year efficacy and safety outcomes of an FDA Investigational Device Exemption randomized controlled trial. The results at both 2 and 7 years ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Join the Conversation
Please Login or Join to leave comments.